Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||ER8734 / 1||UN / IM|
Administered by: Private Purchased by: ??
Symptoms: Activated partial thromboplastin time shortened, Condition aggravated, Diarrhoea, Epistaxis, Fatigue, International normalised ratio normal, Platelet count decreased, Platelet transfusion, Contusion, Occult blood positive, Immunoglobulin therapy, Immune thrombocytopenia
Life Threatening? Yes
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:
Write-up: Approximately 1 week prior to admission patient developed increased bruising and a few minor episodes of epistaxis. She also experienced 1 day of diarrhea which was followed by 4 days of significant fatigue with subsequent improvement. Labs performed by PCP 5/21/2021 showed platelet count of 2000 and when labs resulted on 5/22/2021 patient was instructed to present to the emergency department where her count was repeated and was less than 2000. Patient is receiving 4-day course of IV immune globulin 20 g and prednisone 1 mg/kg (60 mg) daily for 2-3 weeks Patient received 1 unit platelet transfusion in emergency department on 5/22/2021 COVID-19 vaccination could have precipitated relapse of ITP
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166